retatrutide gip glp-1 glucagon receptor agonist Retatrutide: How the Triple Compares to Tirzepatide Use of an unapproved triple-hormone

They share the same three primary receptor targets: GLP-1 GIP Glucagon Because of this shared mechanism, both compounds are part of the broader movement toward multi-agonist incretin drugs designed to influence several metabolic hormone systems simultaneously

Treatment decisions should be made in consultation with qualified healthcare providers who can assess your individual medical history, current health status, and treatment goals

What is the MOQ (minimum order quantity) for wholesale purchases

theyre to keep your entire body healthy through treatment

However, combining Retatrutide with other diabetes medications, particularly sulfonylureas or insulin, increases hypoglycemia risk